LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review

June 2021 | 53 pages | ID: LFFAFA6110FEN
GlobalData

Abstracts

LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for autotransfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, Greater London, the UK.

LivaNova PLC Key Recent Developments

Apr 28,2021: LivaNova Reports First Quarter 2021 Results
Mar 25,2021: LivaNova to Host Conference Call for First Quarter 2021 Results
Feb 24,2021: LivaNova reports fourth quarter and full-year 2020 results
Jan 05,2021: Medistim partners with LivaNova as their new distributor for India
Dec 07,2020: LivaNova announces board appointment and board leadership changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

LivaNova PLC - Key Facts
LivaNova PLC - Key Employees
LivaNova PLC - Key Employee Biographies
LivaNova PLC - Major Products and Services
LivaNova PLC - History
LivaNova PLC - Company Statement
LivaNova PLC - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
LivaNova PLC - Business Description
Business Segment: Cardiovascular
Overview
Performance
Business Segment: Neuromodulation
Overview
Performance
Business Segment: Other
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
LivaNova PLC - Corporate Strategy
LivaNova PLC - SWOT Analysis
SWOT Analysis - Overview
LivaNova PLC - Strengths
LivaNova PLC - Weaknesses
LivaNova PLC - Opportunities
LivaNova PLC - Threats
LivaNova PLC - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

LivaNova PLC, Medical Equipment, Deals By Year, 2015 to YTD 2021
LivaNova PLC, Medical Equipment, Deals By Type, 2015 to YTD 2021
LivaNova PLC, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 28, 2021: LivaNova Reports First Quarter 2021 Results
Mar 25, 2021: LivaNova to Host Conference Call for First Quarter 2021 Results
Feb 24, 2021: LivaNova reports fourth quarter and full-year 2020 results
Jan 05, 2021: Medistim partners with LivaNova as their new distributor for India
Dec 07, 2020: LivaNova announces board appointment and board leadership changes
Dec 04, 2020: LivaNova to host satellite symposium on advances in Neuromodulation at American Epilepsy Society AES2020 virtual event
Oct 29, 2020: LivaNova reports third quarter 2020 results
Jul 29, 2020: LivaNova reports second quarter 2020 results
Jun 29, 2020: LivaNova to Host Conference Call for Second Quarter 2020 Results
Apr 29, 2020: LivaNova reports first quarter 2020 results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

LivaNova PLC, Key Facts
LivaNova PLC, Key Employees
LivaNova PLC, Key Employee Biographies
LivaNova PLC, Major Products and Services
LivaNova PLC, History
LivaNova PLC, Subsidiaries
LivaNova PLC, Key Competitors
LivaNova PLC, Ratios based on current share price
LivaNova PLC, Annual Ratios
LivaNova PLC, Annual Ratios (Cont...1)
LivaNova PLC, Annual Ratios (Cont...2)
LivaNova PLC, Interim Ratios
LivaNova PLC, Medical Equipment, Deals By Year, 2015 to YTD 2021
LivaNova PLC, Medical Equipment, Deals By Type, 2015 to YTD 2021
LivaNova PLC, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

LivaNova PLC, Performance Chart (2016 - 2020)
LivaNova PLC, Ratio Charts
LivaNova PLC, Medical Equipment, Deals By Year, 2015 to YTD 2021
LivaNova PLC, Medical Equipment, Deals by Type, 2015 to YTD 2021